Few studies have explored the effects of PAX3-FOXO1 outside of cancer and as such much remains to be determined on the involvement of PAX3-FOXO1 in joint conditions which may be of significant interest for therapeutic targeting. This evidence concerns the gene FOXO1 and cancer.